RELATED PARTY TRANSACTIONS

12 Months Ended

Dec. 31, 2024

Related Party Transactions [Abstract]

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS

We have an investment in Medalogix, a healthcare predictive data and analytics company, which is accounted for under the equity method. During 2024, 2023 and 2022, we incurred costs of approximately $12.3 million, $11.3 million and $9.4 million, respectively, in connection with our usage of Medalogix's analytics platforms.

We have an investment in a technology-enabled clinician sourcing application, which is accounted for under the cost method. During 2024, 2023 and 2023, we incurred costs of approximately $1.8 million, $0.5 million and less than $0.1 million, respectively, in connection with our usage of the technology-enabled clinician sourcing application's services.